China shares end higher as healthcare firms gain on vaccination efforts

SHANGHAI: China shares closed higher on Thursday, with healthcare shares leading the gains as the country ramped up vaccination efforts amid the emergence of a new cluster of infections.

At the close, the Shanghai Composite index was up 0.08% at 3,482.55.

The blue-chip CSI300 index was up 0.17%, with its healthcare sub-index up 1.74% and the consumer staples sector up 0.97%.

China reported 24 new COVID-19 cases on April 7, with 11 of the new cases were local infections reported in the southwestern Yunnan province.

The country had administered a total of 149.07 million COVID-19 vaccine doses, as of Wednesday.

The real estate index fell 1.75% after Beijing said it would push for property tax.

The National Development and Reform Commission rolled out new measures to relax market entries in the southern island of Hainan, boosting shares of local firms such as Hainan Haide Capital Management Co.

The smaller Shenzhen index ended unchanged for the day and the start-up board ChiNext Composite index was higher by 0.7%.

Around the region, MSCI's Asia ex-Japan stock index was firmer by 0.51%, while Japan's Nikkei index closed down 0.07%.

At 07:01 GMT, the yuan was quoted at 6.5484 per U.S. dollar, 0.07% weaker than the previous close of 6.5435. - Reuters

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3

Shanghai Composite index , CSI300


Next In Business News

J&J COVID-19 vaccine in limbo as US panel delays vote on resuming shots
Oil price climbs nearly 5% on signs of increasing crude demand
GameStop CEO forfeits over 587,000 shares for not meeting targets
Coinbase valued at US$86bil in choppy Nasdaq debut
Wall Street ends mixed despite bumper big-bank earnings
Malaysia bond laggards show signs of recovery
Transocean offers to acquire 40% stake in loss-making Enfrasys
SCIB buys Kencana Precast in expansion plan
Grab – A missed opportunity for Malaysia
Singapore’s MAS holds policy stance while softening dovish tone

Stories You'll Enjoy